The benefit of CRT-D versus defibrillator-only therapy in reducing the risk of HF or death was assessed by LAV ( dichotomized at the upper quartile > 52 mL/m2 ) among 1785 patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy ( MADIT-CRT ) study .